JDD January 2025 Editor’s Picks | Special Focus: Aesthetic Treatments
Welcome to the first issue of the Journal of Drugs in Dermatology for 2025! This issues focuses on the exciting advancements in aesthetic treatments, with editor’s picks that delve into cutting-edge topics shaping dermatology today. From the role of exosomes in cosmetic dermatology to expert insights on managing neuromodulator complications, this issue offers invaluable guidance for pr …
Welcome to the first issue of the Journal of Drugs in Dermatology for 2025! This issues focuses on the exciting advancements in aesthetic treatments, with editor’s picks that delve into cutting-edge topics shaping dermatology today. From the role of exosomes in cosmetic dermatology to expert insights on managing neuromodulator complications, this issue offers invaluable guidance for pr … Continue reading "JDD January 2025 Editor’s Picks | Special Focus: Aesthetic Treatments"
Permethrin is a synthetic neurotoxic pyrethroid derived from chrysanthemums with significant dermatologic value for its powerful insecticide properties when used topically. We continue our series, Therapeutic Cheat Sheet, with a closer look at permethrin, which is FDA-approved for the treatment of scabies and pediculosis capitis infestations.
Permethrin Therapeutic Cheat Sheet
Compiled by: Dillo … 
Treating scarring alopecias in patients with skin of color requires a nuanced understanding of their unique clinical features and challenges. Dr. Susan Taylor, Professor of Dermatology at the University of Pennsylvania Perelman School of Medicine (@drsusantaylor), President-Elect of the American Academy of Dermatology (AAD), and founder of the Skin of Color Society, has devoted her career to impro … 
Ketoconazole is an imidazole antifungal that was initially FDA-approved in an oral formulation for the treatment of systemic fungal infections. While oral ketoconazole has largely fallen out of use due to safety concerns, including hepatotoxicity, endocrine dysregulation, and drug interactions, topical ketoconazole has proven to be a safe and effective treatment for superficial fungal infections. … 
At the Skin of Color Update 2024, we had the honor to learn from Dr. Rebecca Vasquez, Associate Professor at UT Southwestern Medical Center, regarding the evolving field of vitiligo management. Vitiligo affects between 0.5% to 2% of the global population, with no racial or gender preference, yet it carries a significant psychological burden for affected individuals.1 Dr. Vasquez emphasized that vi … 